How did SABS's Q2 2024 EPS forecast compare to past trends

Symbols

How did SABS's Q2 2024 EPS forecast compare to past trends?

4/10/2025 04:32am

Aime

SAB Biotherapeutics (SABS) is forecasted to report an EPS of -$1.13 for Q2 2024, which is worse than the -$0.79 reported in Q2 2023¹². This indicates a potential decline in the company's earnings, suggesting a negative outlook for the period.

1/2

Source:

1. SABS EPS in the past five years with focus on Q2 2024

more